E

EDAP TMS SA
D

EDAP

1.70000
USD
-0.01
(-0.58%)
Market Closed
Volume
0
EPS
-1
Div Yield
-
P/E
-3
Market Cap
63,566,546
Related Instruments
BAX
BAX
0.200
(0.67%)
30.000 USD
HOLX
HOLX
0.540
(0.84%)
64.500 USD
ISRG
ISRG
-0.37
(-0.07%)
509.16 USD
MDT
MDT
0.615
(0.72%)
86.340 USD
RMD
RMD
2.810
(1.12%)
253.670 USD
SYK
SYK
2.27
(0.61%)
375.55 USD
TMO
TMO
5.21
(1.33%)
397.73 USD
More
News

Title: EDAP TMS SA

Sector: Healthcare
Industry: Medical Distribution
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Itsgeographical segments are Asia, France, United States, and Others.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.